Encompass Health (EHC) traded lower on Tuesday, May 5, 2026, extending a giveback after last week’s earnings-driven jump. A new filing highlighting share sales by a large institutional holder added to “profit-taking” pressure as the market rotated out of recent winners and reassessed valuation following the quick run-up.

The decline follows a sharp move higher after Encompass Health reported first-quarter results and lifted its full-year outlook. In its April 30, 2026 update, Encompass Health guided to FY2026 adjusted EPS of $5.89–$6.11 and net operating revenue of $6.375–$6.470 billion, a setup that helped drive a strong reaction but also raised the bar for further upside in the near term.

With no new company operating update required to explain a ~3% pullback, traders are likely focused on positioning signals and whether additional holders disclose trimming after the earnings pop. Key near-term swing factors include any follow-on analyst actions, changes in short-term flows, and whether management commentary from the Q1 period (capacity expansion, labor efficiency, and payer dynamics) continues to translate into steady volume and margin execution into the summer.